Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
Mayo Clinic
Mayo Clinic
National Cancer Institute, Naples
Regor Pharmaceuticals Inc.
Hospital Universitari de Bellvitge
University of Rochester
Radboud University Medical Center
Centre hospitalier de l'Université de Montréal (CHUM)
Cogent Biosciences, Inc.
Rutgers, The State University of New Jersey
GlaxoSmithKline
Qilu Pharmaceutical Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Kaiser Permanente
Ellele Health
Mayo Clinic
University Hospital, Strasbourg, France
University of Southern California
Asan Medical Center
European Institute of Oncology
UNC Lineberger Comprehensive Cancer Center
Women's Hospital School Of Medicine Zhejiang University
University Hospital Hradec Kralove
Taipei Veterans General Hospital, Taiwan
European Institute of Oncology
Natera, Inc.
Medical College of Wisconsin
UNC Lineberger Comprehensive Cancer Center
Second Life Therapeutics
Peking Union Medical College Hospital
National Cancer Institute, Naples
Rocky Vista University, LLC
Assiut University
Sun Yat-sen University
Centre Leon Berard
University College, London
Centre Georges Francois Leclerc
GlaxoSmithKline
Peking University People's Hospital
Seoul National University Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Tongji Hospital
University Health Network, Toronto
Hospital Italiano de Buenos Aires
Cycle Therapeutics Ltd
Peking University People's Hospital
University of South Florida
Istanbul University
Erasmus Medical Center
Universidade Federal de Pernambuco